X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (95) 95
index medicus (92) 92
female (78) 78
male (74) 74
middle aged (71) 71
aged (67) 67
adult (58) 58
hematology (50) 50
oncology (49) 49
aged, 80 and over (40) 40
survival (39) 39
rituximab (32) 32
chemotherapy (29) 29
cancer (27) 27
prognosis (26) 26
antineoplastic combined chemotherapy protocols - therapeutic use (25) 25
retrospective studies (24) 24
treatment outcome (24) 24
young adult (21) 21
adolescent (20) 20
analysis (19) 19
lymphomas (19) 19
follow-up studies (18) 18
disease-free survival (17) 17
diagnosis (16) 16
follicular lymphoma (16) 16
neoplasm staging (16) 16
antineoplastic combined chemotherapy protocols - administration & dosage (15) 15
antineoplastic combined chemotherapy protocols - adverse effects (15) 15
lymphoma (14) 14
care and treatment (13) 13
risk factors (13) 13
survival analysis (13) 13
therapy (13) 13
combination (12) 12
disease (12) 12
expression (12) 12
italy (12) 12
kaplan-meier estimate (12) 12
lymphoma, follicular - drug therapy (12) 12
non-hodgkins-lymphoma (12) 12
risk (11) 11
survival rate (11) 11
cyclophosphamide (10) 10
doxorubicin - administration & dosage (10) 10
lymphoma, follicular - pathology (10) 10
antineoplastic agents - therapeutic use (9) 9
incidence (9) 9
italy - epidemiology (9) 9
non-hodgkin's lymphomas (9) 9
proportional hazards models (9) 9
research (9) 9
chop (8) 8
cyclophosphamide - administration & dosage (8) 8
hodgkin disease - drug therapy (8) 8
internal medicine (8) 8
medicine & public health (8) 8
multivariate analysis (8) 8
non-hodgkin lymphoma (8) 8
non-hodgkins-lymphomas (8) 8
outcomes (8) 8
prednisone - administration & dosage (8) 8
prospective studies (8) 8
registries (8) 8
time factors (8) 8
trial (8) 8
vincristine - administration & dosage (8) 8
antibodies, monoclonal, murine-derived - administration & dosage (7) 7
apoptosis (7) 7
b-cell lymphoma (7) 7
bendamustine (7) 7
breast cancer (7) 7
lenalidomide (7) 7
lymphoma, follicular - mortality (7) 7
medicine, general & internal (7) 7
patients (7) 7
peripheral vascular disease (7) 7
positron-emission-tomography (7) 7
recurrence (7) 7
response criteria (7) 7
surgery (7) 7
abridged index medicus (6) 6
animals (6) 6
antibodies, monoclonal, murine-derived - therapeutic use (6) 6
antineoplastic agents - administration & dosage (6) 6
bleomycin - administration & dosage (6) 6
cancer research (6) 6
cell biology (6) 6
doxorubicin (6) 6
drug therapy (6) 6
fludarabine (6) 6
hodgkin disease - mortality (6) 6
medical research (6) 6
open-label (6) 6
radiotherapy (6) 6
vidarabine - administration & dosage (6) 6
vidarabine - analogs & derivatives (6) 6
1st-line treatment (5) 5
age (5) 5
antibodies, monoclonal, murine-derived - adverse effects (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Hematological Oncology, ISSN 0278-0232, 12/2017, Volume 35, Issue 4, pp. 561 - 566
Journal Article
Journal of Breast Cancer, ISSN 1738-6756, 12/2015, Volume 18, Issue 4, pp. 378 - 385
Evolving therapies have improved the prognoses of patients with breast cancer; and currently, the number of long-term survivors is continuously increasing.... 
Breast neoplasms | Human epidermal growth factor receptor 2 | Case-Control Studies | Second primary neoplasms | Case-control studies | WOMEN | ONCOLOGY | GROWTH | PRIMARY NONBREAST CANCER | RADIOTHERAPY | FAMILY | AGE | Original | 일반외과학
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2009, Volume 27, Issue 27, pp. 4555 - 4562
Purpose The aim of the F2 study was to verify whether a prospective collection of data would enable the development of a more accurate prognostic index for... 
SURVIVAL | TRIAL | LOW-GRADE LYMPHOMA | RESPONSE CRITERIA | ONCOLOGY | RITUXIMAB | SERUM BETA-2-MICROGLOBULIN | NON-HODGKINS-LYMPHOMA | MODEL | MULTIVARIATE-ANALYSIS | PREDICTION
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 07/2019, Volume 60, Issue 8, pp. 1958 - 1964
It is well established that some patients with diffuse large B-cell lymphoma (DLBCL) and the negative end of treatment PET-CT (EOT-PET-CT) will relapse, while... 
EOT-PET-CT | DLBCL | prognosis | AMC | TOMOGRAPHY | CRITERIA | RESPONSE ASSESSMENT | RATIO | TRIAL | ONCOLOGY | PREDICTS SURVIVAL | RITUXIMAB ERA | HEMATOLOGY
Journal Article
Apoptosis, ISSN 1360-8185, 06/2017, Volume 22, Issue 6, pp. 827 - 840
Histone deacetylase inhibitors (HDACis) have emerged as a new class of anticancer agents, targeting the biological process including cell cycle and apoptosis.... 
Bendamustine | Synergistic effect | Lymphoma | Ricolinostat | Apoptosis | MULTIPLE-MYELOMA | MULTICENTER | AGGRESOME FORMATION | ACY-1215 | ACETYLATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | MECHANISMS | CELL BIOLOGY | THIOREDOXIN | IN-VIVO | LENALIDOMIDE | HISTONE DEACETYLASE INHIBITORS | Bendamustine Hydrochloride - therapeutic use | Reactive Oxygen Species - metabolism | Apoptosis - drug effects | Humans | Lymphoma, Non-Hodgkin - pathology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Histone Deacetylase 6 - metabolism | Lymphoma - drug therapy | Mesenchymal Stromal Cells - cytology | Microtubules - metabolism | Tubulin - metabolism | Caspases - metabolism | Microtubules - drug effects | Interleukin-10 - metabolism | Lymphoma - pathology | Clone Cells | Proto-Oncogene Proteins c-akt - metabolism | Hydroxamic Acids - pharmacology | Lymphoma, Non-Hodgkin - drug therapy | Cell Survival - drug effects | Mesenchymal Stromal Cells - drug effects | Endoplasmic Reticulum Stress - drug effects | Histone Deacetylase 6 - antagonists & inhibitors | Cell Cycle Proteins - metabolism | Pyrimidines - pharmacology | Enzyme Activation - drug effects | Drug Synergism | Acetylation - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrimidines - therapeutic use | Bendamustine Hydrochloride - pharmacology | Cell Line, Tumor | Histone Deacetylase Inhibitors - pharmacology | Hydroxamic Acids - therapeutic use | Cell Proliferation - drug effects | Histone Deacetylase Inhibitors - therapeutic use | Proto-Oncogene Proteins c-bcl-2 | Cell Cycle - drug effects
Journal Article
Journal Article
Journal Article
Haematologica, ISSN 0390-6078, 03/2008, Volume 93, Issue 3, pp. 398 - 404
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 03/2017, Volume 58, Issue 3, pp. 552 - 559
Journal Article